Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CFFN | UVSP |
|---|---|---|
| Price | $8.42 | $40.89 |
| Change today | ▼ 1.17% | ▼ 1.16% |
| Market cap | $1.06B | $1.13B |
| Return, 3 months | +0.2% | -6.2% |
| Return, year to date | +28.4% | +27.1% |
| Return, 1 year | +40.7% | +40.5% |
| P/E (TTM) | 13.0 | 11.8 |
| P/B | 1.0 | 1.2 |
| P/E percentile vs own 5y | 38th | 86th |
| Dividend yield | 4.04% | 2.18% |
| Revenue growth (YoY, latest qtr) | +19.0% | +4.1% |
| Net profit growth (YoY) | +28.2% | +14.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 36.5% | 29.0% |
| Return on equity | 8.0% | 10.5% |
| Analyst target vs. price | +9.9% | +14.9% |
| Analyst buy share | 0% | 0% |
| RSI (14) | 40 | 38 |
| 30-day volatility | 17.1% | 12.2% |
| Max drawdown, 1 year | -10.6% | -9.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
